Hamid Erfanian - 13 Apr 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role: Chief Executive Officer
Signature: /s/ Hamid Erfanian
Issuer symbol: ENZB
Transactions as of: 13 Apr 2022
Net transactions value: +$29,000
Form type: 4
Filing time: 14 Apr 2022, 13:52:56 UTC
Previous filing: 10 Nov 2021
Next filing: 17 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZ	Common Stock, $0.01 Par Value	Award	$29,000	+10,000	+3.8%	$2.90	270,000	13 Apr 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENZ	Stock Option (to acquire Common Stock)	Award	$0	+700,000		$0.000000	700,000	08 Nov 2021	Common Stock	700,000	$3.39	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.